v3.25.2
18. STOCK OPTION PLAN
6 Months Ended
Jun. 30, 2025
Notes  
18. STOCK OPTION PLAN

18.STOCK OPTION PLAN 

 

On March 27, 2020, the Company adopted an incentive stock option plan (the “Plan”). The Plan allows the Board of Directors of the Company to grant options to acquire shares of common stock of the Company to directors, officers, key employees and consultants. The option price, term and vesting periods are determined at the discretion of the Board of Directors, subject to certain restrictions as required by the policies of Section 422 of the Internal Revenue Code. The Plan is a fixed number plan with a maximum of 1,666,667 shares of common stock reserved for issuance under the Plan.

 

On September 7, 2024, the Company amended the 2020 Stock Plan to increase the number of shares of common stock of the Corporation available for grant under the plan from 1,666,666 (as adjusted for the 1 for 3 reverse split) to 4,000,000.

 

 

The table below sets forth share options outstanding as of June 30, 2025.

 

Grant

Date

Options

Outstanding

Exercise

Price

Expiration

Vesting

September 1,

2022

336,114

$ 2.70

August

31, 2027

Equally over 3 years commencing on first anniversary of grant date

October 5,

2023

446,338

4.80

October 14,

2028

Equally over 3 years commencing on first anniversary of grant date

November 1,

2023

83,334

4.80

October 31, 2028

31,112 vest immediately, remaining vest equally over 3 years commencing on first anniversary of grant date

November 22,

2024

66,667

1.47

November 23, 2027

Equally over 3 years commencing on first anniversary of grant date

 

During the six months ended June 30, 2025 and 2024, the Company recorded share-based compensation expense of $309,354 and $459,968, respectively. During the three months ended June 30, 2025 and 2024, the Company recorded share-based compensation expense of $230,474 and $189,792, respectively.

 

As of June 30, 2025, the Company had $208,316 of unrecognized share-based compensation costs related to non-vested awards that will be recognized over a weighted average period of 3 years. As of June 30, 2025, 522,857 options have vested, and are exercisable. The options issued during 2022 vest equally over 3 years commencing on the first anniversary of the grant date. Of the options issued during 2023, 31,112 vested immediately on grant date, with the remaining options vesting equally over 3 years commencing on the first anniversary of the grant date.

 

The following sets forth the outstanding common share options and related activity for the period ended June 30, 2025:

 

 

 

Number of

Options

Weighted Average

Exercise Price

Per Share

Outstanding as of December 31, 2024

 

932,453   

$ 3.80   

Granted

 

-   

-   

Exercised

 

-   

-   

Forfeited

 

-   

-   

Outstanding as of June 30, 2025

 

932,453   

$ 3.80